These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23250862)

  • 21. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N; Melamed E; Offen D
    Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.
    Shaikh S; Nicholson LF
    J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
    Kardani J; Roy I
    ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.
    Duka T; Sidhu A
    Neurotox Res; 2006 Aug; 10(1):1-10. PubMed ID: 17000465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.
    Jain MK; Bhat R
    Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
    Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model.
    Rcom-H'cheo-Gauthier AN; Davis A; Meedeniya ACB; Pountney DL
    Mol Cell Neurosci; 2016 Dec; 77():65-75. PubMed ID: 27746320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease.
    Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rab7 induces clearance of α-synuclein aggregates.
    Dinter E; Saridaki T; Nippold M; Plum S; Diederichs L; Komnig D; Fensky L; May C; Marcus K; Voigt A; Schulz JB; Falkenburger BH
    J Neurochem; 2016 Sep; 138(5):758-74. PubMed ID: 27333324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of alpha-synuclein aggregation by intracellular nitrative insult.
    Paxinou E; Chen Q; Weisse M; Giasson BI; Norris EH; Rueter SM; Trojanowski JQ; Lee VM; Ischiropoulos H
    J Neurosci; 2001 Oct; 21(20):8053-61. PubMed ID: 11588178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology.
    Li X; Koudstaal W; Fletcher L; Costa M; van Winsen M; Siregar B; Inganäs H; Kim J; Keogh E; Macedo J; Holland T; Perry S; Bard F; Hoozemans JJ; Goudsmit J; Apetri A; Pascual G
    Acta Neuropathol; 2019 May; 137(5):825-836. PubMed ID: 30805666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
    Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
    J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
    Verhaar R; Jongenelen CA; Gerard M; Baekelandt V; Van Dam AM; Wilhelmus MM; Drukarch B
    Neurochem Int; 2011 Jun; 58(7):785-93. PubMed ID: 21440023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.
    Emmanouilidou E; Melachroinou K; Roumeliotis T; Garbis SD; Ntzouni M; Margaritis LH; Stefanis L; Vekrellis K
    J Neurosci; 2010 May; 30(20):6838-51. PubMed ID: 20484626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.
    Welander H; Bontha SV; Näsström T; Karlsson M; Nikolajeff F; Danzer K; Kostka M; Kalimo H; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2011 Aug; 412(1):32-8. PubMed ID: 21798243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time determination of aggregated alpha-synuclein induced membrane disruption at neuroblastoma cells using scanning ion conductance microscopy.
    Wong Su S; Chieng A; Parres-Gold J; Chang M; Wang Y
    Faraday Discuss; 2018 Oct; 210(0):131-143. PubMed ID: 29974096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.